Candel Therapeutics names Mark Sims as chief commercial officer
Go back to Candel Therapeutics names Mark Sims as chief commercial officer| (NASDAQ: CADL) | Delayed: 11.29 -0.56 (4.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.85 | 52 Week High | $ | |||
| Open | $11.93 | 52 Week Low | $ | |||
| Day High | $12.01 | P/E | N/A | |||
| Day Low | $11.27 | EPS | $ | |||
| Volume | 1,284,304 | |||||
